Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.
| Last: | $3.155 |
|---|---|
| Change Percent: | -6.24% |
| Open: | $3.29 |
| Close: | $3.365 |
| High: | $3.365 |
| Low: | $3.12 |
| Volume: | 45,987 |
| Last Trade Date Time: | 02/27/2026 12:34:34 pm |
| Market Cap: | $56,129,625 |
|---|---|
| Float: | 4,556,882 |
| Insiders Ownership: | 19.47% |
| Institutions: | 14 |
| Short Percent: | N/A |
| Industry: | Capital Markets |
| Sector: | Finance |
| Website: | https://www.dominariholdings.com |
| Country: | US |
| City: | New York |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Dominari Holdings Inc. (NASDAQ: DOMH).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.